Hepatitis B

Citations 1-10 of 49 total displayed.

Hepatology
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

G L-H Wong, V W-S Wong, P C-L Choi, A W-H Chan, A M-L Chim, K K-L Yiu, H-Y Chan, F K-L Chan, J J-Y Sung, and H L-Y Chan
Gut 2009 58: 111 -117; published online before print as 10.1136/gut.2008.157735 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatology
Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China

H W Zhang, J H Yin, Y T Li, C Z Li, H Ren, C Y Gu, H Y Wu, X S Liang, P Zhang, J F Zhao, X J Tan, W Lu, S Schaefer, and G W Cao
Gut 2008 57: 1713 -1720; published online before print as 10.1136/gut.2008.157149 [Abstract] [Full text] [PDF] [Request Permissions]  

Leading articles
Chronic viral hepatitis in children: any role for the pathologist?

Maria Guido and Flavia Bortolotti
Gut 2008; 57: 873-877. [Extract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection

G V Papatheodoridis, E Hadziyannis, E Tsochatzis, N Chrysanthos, A Georgiou, G Kafiri, S Manolakopoulos, D G Tiniakos, I Giannousis, E K Manesis, and A J Archimandritis
Gut 2008 57: 500 -506; published online before print as 10.1136/gut.2007.123943 [Abstract] [Full text] [PDF] [Request Permissions]  

Recent advances in clinical practice
Current treatment of hepatitis B

G Dusheiko and N Antonakopoulos
Gut 2008 57: 105 -124; published online before print as 10.1136/gut.2005.077891 [Extract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil

J E Yeon, W Yoo, S P Hong, Y J Chang, S K Yu, J H Kim, Y S Seo, H J Chung, M S Moon, S-O Kim, K S Byun, and C H Lee
Gut 2006 55: 1488 -1495; published online before print as 10.1136/gut.2005.077099 [Abstract] [Full text] [PDF] [Request Permissions] [ web only table ] [ conflict of interest ]  

Hepatitis
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon -2b therapy

H J Flink, D Sprengers, B E Hansen, M van Zonneveld, R A de Man, S W Schalm, H L A Janssen for the HBV 99-01 study group
Gut 2005 54: 1604 -1609; published online before print as 10.1136/gut.2004.062208 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

M-F Yuen, H-J Yuan, D K-H Wong, J C-H Yuen, W-M Wong, A O-O Chan, B C-Y Wong, K-C Lai, and C-L Lai
Gut 2005 54: 1610 -1614; published online before print as 10.1136/gut.2005.065136 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatitis
CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter

F Tacke, C Liedtke, S Bocklage, M P Manns, and C Trautwein
Gut 2005 54: 1309 -1317; published online before print as 10.1136/gut.2005.065086 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D

A Erhardt, D Blondin, K Hauck, A Sagir, T Kohnle, T Heintges, and D Häussinger
Gut 2005; 54: 1009-1013. [Abstract] [Full text] [PDF] [Request Permissions]